Guaiacylglycerol-7′-O-methyl 8′-vanillic acid ether and related compounds from Boreava orientalis

Phytochemical Analysis

Volumn 14, Issue 1, 2003, Pages 48-53

  Sakushima, Akiyo ^a   Ohno, Kosei ^a   Maoka, Takashi ^b   Coskun, Maksut ^c   Guvenc, Aysegul ^c   Erdurak, Ceyda Sibel ^c   Ozkan, Ayse Mine ^c   Seki, Koh Ichi ^a   Ohkura, Kazue ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Boreava orientalis; Cruciferae; Guaiacylglycerol ether; Lignan; Threo and erythro guaiacylglycerol 8 vanillin ethers; Threo and erythro guaiacylglycerol 7 O methyl 8 vanillic acid ethers; Threo guaiacylglycerol 8 (4 hydroxymethyl 2 methoxyphenyl) ether

Indexed keywords

BINARY ALLOYS; GLYCEROL;

BOREAVUM ORIENTALI; CRUCIFERA; ERYTHRO; GUAIACYLGLYCEROL ETHER; LIGNANS; THREO AND ERYTHRO GUAIACYLGLYCEROL 8′-VANILLIN ETHER; THREO AND ERYTHRO GUAIACYLGLYCEROL-7′-O-METHYL 8′-VANILLIC ACID ETHER; THREO GUAIACYLGLYCEROL 8′-(4-HYDROXYMETHYL-2-METHOXYPHENYL) ETHER; VANILLIC ACIDS;

ETHERS;

BOREAVA EXTRACT; GUAIACYLGLYCEROL 7' O METHYL 8' VANILLIC ACID ETHER; PLANT EXTRACT; UNCLASSIFIED DRUG; DRUG DERIVATIVE; GUAIFENESIN;

ARTICLE; BOREAVA; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG ISOLATION; DRUG STRUCTURE; FRUIT; MASS SPECTROMETRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOISOMERISM; STRUCTURE ANALYSIS; ULTRAVIOLET SPECTROSCOPY; WEED; BRASSICACEAE; CHEMICAL STRUCTURE; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

BOREAVA ORIENTALIS; BRASSICACEAE;

BRASSICACEAE; GUAIFENESIN; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE;

EID: 0037273108     PISSN: 09580344     EISSN: None     Source Type: Journal    
DOI: 10.1002/pca.686     Document Type: Article

References (16)

1. Brunow G and Lundguist K. 1991. On the acid-catalysed alkylation of lignins. Holzforsch 45: 37-40.
2. Graziano J, Grady RW and Cerami A. 1974. The identification of 2,3-dihydroxybenzoic acid as a potentially useful iron-chelating drug. J Pharm Exp Therapeut 190: 570-575.
3. Hattori M, Hada S, Watahiki A, Ihara H, Shu Y-Z, Kakiuchi N, Mizuno T and Namba T. 1986. Studies on dental caries prevention by traditional medicines. X. Antibacterial action of phenolic compounds from mace against Streptcoccus mutans. Chem Pharm Bull 34: 3885-3893.
4. Houghton PJ. 1985. Lignans and neolignans from Buddleja davidii. Phytochemistry 24: 819-826.
5. Katayama T, Nakatsubo F and Higuchi T. 1980. Initial reactions in the fungal degradation of guaiacylglycerol-β-coniferyl ether, a lignan substructure model. Arch Microbiol 126: 127-132.
6. Katayama T, Nakatsubo F and Higuchi T. 1981. Syntheses of arylglycerol-β-aryl ethers. Mokuzai Gakkaishi 27: 223-230.
7. Maoka T, Sakushima A, Coskun M and Ito H. 1996. Anti-oxidative activity of phenolic compounds of Boreava orientalis. J Jap Oil Chem Soc 45: 671-673.
8. Maoka T, Ito H, Sakushima A, Ohno K, Coskun M and Nishibe S. 1997. Comparison of anti-oxidative activity of phenolic compounds in Boreava orientalis and their relative compounds. J Jap Oil Chem Soc 46: 1399-1402.
9. Miki K, Takehara T, Sasaya T and Sakakibara A. 1980. Lignans of Larix leptolepis. Phytochemistry 19: 449-453.
10. Rice-Evans CA and Packer L. 1998. The Flavonoids in Health and Disease. Marcel Dekker: New York; 35-59.
11. Sakushima A, Coskun M, Tanker M and Tanker N. 1994. A sinapic acid ester from Boreava oreientalis. Phytochemistry 35: 1481-1484.
12. Sakushima A, Coskun M and Maoka T. 1995. Hydroxybenzoic acids from Boreava orientalis. Phytochemistry 40: 257-261.
13. Sakushima A, Coskun M, Maoka T and Nishibe S. 1997. Separation of guaiacylglycerol-8′-vanillic acid ether isomers from Boreava orientalis. Nat Prod Lett 11: 31-36.
14. Shen X and Heiningen AV. 1992. Synthesis of β-O-4 lignin model dimmers and their chlorinated derivatives. Can J Chem 70: 1754-1761.
15. Tanker M and Yenen M. 1978. Boreava orientalis. J Fac Pharm Ankara Univ 8: 1.
16. Tanker M, Ertan M, Coskun M, Sariseker N and Yurdesin T. 1983. The investigation of possibilities in Turkey with regards to the antibiotic industry. Turkish J Med Sci 7:99-108. f